# BENDAMUSTINE HYDROCHLORIDE
> **NDA211530** · New Drug Application · Sponsor: HOSPIRA · Approved 2022-12-15
## Drug
- **FDA Application Number:** NDA211530
- **Application type:** New Drug Application
- **Brand name:** BENDAMUSTINE HYDROCHLORIDE
- **Generic name:** Bendamustine Hydrochloride
- **Active ingredients:** BENDAMUSTINE HYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** HOSPIRA
- **First approval:** 2022-12-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211530)
---
*MORVS · CC0 1.0*